March 23, 2020 / 10:44 AM / 15 days ago

BRIEF-Lilly Provides Update On Clinical Trial Activities During Covid-19 Pandemic

March 23 (Reuters) - Eli Lilly and Co:

* LILLY PROVIDES UPDATE ON CLINICAL TRIAL ACTIVITIES DURING COVID-19 PANDEMIC

* ELI LILLY AND CO - COMPANY WILL DELAY MOST NEW STUDY STARTS AND PAUSE ENROLLMENT IN MOST ONGOING STUDIES.

* ELI LILLY AND CO - LILLY IS CONTINUING ONGOING CLINICAL TRIALS FOR PATIENTS WHO ARE ALREADY ENROLLED.

* ELI LILLY AND CO - DOES NOT ANTICIPATE A CHANGE TO ITS 2020 FINANCIAL GUIDANCE AS A RESULT OF COVID-19.

* ELI LILLY AND CO - CONTINUES TO TAKE STEPS NECESSARY TO MAINTAIN SUPPLY OF ALL OF ITS MEDICINES AROUND WORLD

* ELI LILLY - DOES NOT EXPECT ADJUSTMENTS TO PREVIOUSLY COMMUNICATED TIMELINES FOR ONGOING LATE-STAGE STUDIES, EXCEPT FOR MIRIKIZUMAB’S GI INDICATIONS

* ELI LILLY, ON COVID-19, SAYS REPURPOSED LABORATORIES TO CONDUCT DIAGNOSTIC TESTING FOR PATIENTS AND ARE RESEARCHING POTENTIAL THERAPEUTICS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below